BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$2.81B |
| 2 |
Linde
LIN
|
+$2.35B |
| 3 |
Chevron
CVX
|
+$1.53B |
| 4 |
Pfizer
PFE
|
+$1.38B |
| 5 |
UnitedHealth
UNH
|
+$1.35B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$3.75B |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.23B |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$1.1B |
| 4 |
Baidu
BIDU
|
+$1.07B |
| 5 |
NXP Semiconductors
NXPI
|
+$998M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.27% |
| 2 | Healthcare | 15.23% |
| 3 | Financials | 12.33% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
iShares International Select Dividend ETF
IDV
$8.48B
| $27M | ﹤0.01% |
995,664
+256,854
| +35% | +$7.74M |
|
2902
Adicet Bio
ACET
$74.2M
| $27M | ﹤0.01% |
115,568
+14,436
| +14% | +$3.17M |
|
2903
Sun Life Financial
SLF
$45.6B
| $27M | ﹤0.01% |
588,652
+54,511
| +10% | +$2.72M |
|
2904
Microvast
MVST
$261M
| $26.9M | ﹤0.01% |
12,133,129
+8,421,981
| +227% | +$36.2M |
|
|
BASE
2905
DELISTED
Couchbase
BASE
| $26.9M | ﹤0.01% |
1,638,752
+435,738
| +36% | +$6.88M |
|
2906
Business First Bancshares
BFST
$1.03B
| $26.9M | ﹤0.01% |
1,262,552
+38,647
| +3% | +$857K |
|
2907
TriSalus Life Sciences
TLSI
$299M
| $26.9M | ﹤0.01% |
2,728,951
| – | – |
|
2908
Barclays
BCS
$95B
| $26.9M | ﹤0.01% |
3,534,702
-728,932
| -17% | -$5.72M |
|
2909
CALL
Otis Worldwide
OTIS
$28.1B
| $26.8M | ﹤0.01% |
+379,700
| New | +$28M |
|
2910
MaxCyte
MXCT
$119M
| $26.8M | ﹤0.01% |
5,663,419
+219,582
| +4% | +$1.08M |
|
2911
Stagwell
STGW
$2.23B
| $26.7M | ﹤0.01% |
4,922,097
+575,745
| +13% | +$4.08M |
|
|
DICE
2912
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $26.7M | ﹤0.01% |
1,718,712
+858,172
| +100% | +$14.8M |
|
|
SEI
2913
Solaris Energy Infrastructure
SEI
$3.49B
| $26.7M | ﹤0.01% |
2,450,553
-140,000
| -5% | -$1.69M |
|
2914
Vaalco Energy
EGY
$552M
| $26.7M | ﹤0.01% |
3,840,521
+2,866,544
| +294% | +$20.5M |
|
2915
MiMedx Group
MDXG
$609M
| $26.6M | ﹤0.01% |
7,655,170
+372,395
| +5% | +$1.46M |
|
2916
RLJ Lodging Trust $1.95 Series A Preferred Stock
RLJ.PRA
$322M
| $26.5M | ﹤0.01% |
1,020,876
-11,399
| -1% | -$300K |
|
2917
Distribution Solutions Group
DSGR
$1.61B
| $26.5M | ﹤0.01% |
1,029,796
+295,214
| +40% | +$6.16M |
|
2918
Treace Medical Concepts
TMCI
$284M
| $26.4M | ﹤0.01% |
1,843,561
+238,372
| +15% | +$4.02M |
|
2919
Xenon Pharmaceuticals
XENE
$6.24B
| $26.4M | ﹤0.01% |
868,290
+253,333
| +41% | +$7.66M |
|
2920
VSE Corp
VSEC
$6.33B
| $26.4M | ﹤0.01% |
701,186
+11,070
| +2% | +$434K |
|
|
LUCK
2921
Lucky Strike Entertainment
LUCK
$911M
| $26.3M | ﹤0.01% |
2,488,013
+2,002,691
| +413% | +$21.3M |
|
|
FIRY
2922
Firy Inc
FIRY
$156M
| $26.3M | ﹤0.01% |
1,062,384
+485,732
| +84% | +$19M |
|
2923
Rayonier Advanced Materials
RYAM
$620M
| $26.3M | ﹤0.01% |
10,045,056
+73,579
| +0.7% | +$330K |
|
2924
Vishay Precision Group
VPG
$906M
| $26.3M | ﹤0.01% |
902,343
-482
| -0.1% | -$14.8K |
|
2925
Workhorse Group
WKHS
$35.2M
| $26.2M | ﹤0.01% |
3,359
-19
| -0.6% | -$179K |
|
Similar funds
BlackRock's Q2 2022 Portfolio in Review
As of Q2 2022, BlackRock held 6,138 positions worth $3.12T, down 16% from $3.71T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q2 2022 filing shows 278 new, 2,738 increased, 2,354 reduced and 221 closed positions. Its largest new stake was Aspen Technology Inc: 2,824,931 shares worth $519M. The largest sale was AT&T, an estimated $3.75B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2022 buy was Aspen Technology Inc: 2,824,931 shares worth $519M.
- BlackRock added most to Warner Bros in Q2 2022, an estimated $2.81B increase.
- BlackRock's biggest Q2 2022 reduction was AT&T, cutting an estimated $3.75B.
- BlackRock fully exited Cerner Corp in Q2 2022, selling an estimated $2.23B.
- BlackRock's ten largest holdings make up 19% of its $3.12T portfolio in Q2 2022.
- BlackRock opened 278 new positions and closed 221 in Q2 2022.
- BlackRock's portfolio value fell 16% quarter-over-quarter to $3.12T.
Based on BlackRock's 13F filing for Q2 2022, filed 12 Aug 2022.